- ABOUT US
Our intellectual property position has been enabled by our capability to sequence full-length genes and attribute specific utilities to them. We test multiple versions of the same gene, often from more than one plant species, to maximize the depth and breadth of our intellectual property position. Our intellectual property approach and portfolio have been validated by industry-leading licensing agreements.
We own or have exclusive licensed rights to approximately 90 issued patents and 110 patent pending applications in the United States and in various foreign jurisdications.*
* As of February 14, 2014